Pramipexole, a Parkinson’s disease (PD) drug, impairs decision-making by hyperactivating the brain’s external globus pallidus ...

Parkinson's is caused by the loss of neurons that produce dopamine, PPX binds to dopamine receptors in the brain.

Using a large population-based cohort of users of anti-Parkinsonian drugs, we found that the use of pramipexole is not associated with an increase in the risk of severe pneumonia requiring ...

A new report sheds light on how a Parkinson’s disease drug may impair decision-making and lead to harmful behaviors like ...

A team from Carnegie Mellon University's Robotics Institute (RI) has developed Neural Motion Planning to help improve how ...

Linking brain activity to behavior is challenging due to the complexity of brain activity, as measured by tools like fMRI. In ...

Researchers have investigated the mechanism by which a drug called pramipexole impairs the decision-making process in mice ...

Mice with Parkinson’s Disease and treated with pramipexole show poor decision-making skills in a gambling task, as seen on the left. This is caused by increased activity in the external globus ...

Review the side-effects of Pramipexole as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Pramipexole dihydrochloride extended-release 0.375mg, 0.75mg, 1.5mg, 2.25mg, 3mg, 3.75mg, 4.5mg; tabs. Swallow whole. May take with food. Initially 0.375mg once daily ...

The drugs that are used first to treat restless legs syndrome most often include ropinirole, pramipexole, and rotigotine. The drug gabapentin enacarbil is also used, but usually only when the ...

Parkinson's disease (PD), also known simply as Parkinson's, is a disorder of the nervous system that affects millions of ...